biomarker-directed, multi-drug, phase 1b trial in bladder cancer
Published 8 years ago • 83 plays • Length 1:25Download video MP4
Download video MP3
Similar videos
-
11:35
update on first biomarker-directed trial of non-muscle-invasive bladder cancer
-
0:57
biomarkers for muscle-invasive bladder cancer in the ambassador trial
-
3:00
biomarker-directed biscay data: durvalumab plus targeted therapies in muc
-
1:44
positive biomarkers to select patients for bladder preservation in bladder cancer
-
1:08
the role of molecular biomarkers in determining patient response to bladder cancer treatment
-
2:48
using biomarkers to identify bladder cancer patients for neoadjuvant therapy
-
1:47
current and upcoming clinical trials in bladder cancer
-
3:03
what is a biomarker? - bladder cancer video library
-
2:52
pd-l1 and tmb as biomarkers in the imvigor211 trial of atezolizumab vs. chemo for bladder cancer
-
1:28
advances in biomarker-directed therapies for gastric cancer
-
3:41
what is a biomarker? - bladder cancer video library
-
2:36
imvigor010 & imvigor011: ctdna as a response biomarker for adjuvant atezolizumab in high-risk mibc
-
0:47
role of predictive biomarkers in patients with mibc
-
1:25
overcoming challenges in localized bladder cancer management via biomarkers
-
2:41
should pd-l1 be used as a biomarker for immunotherapy in bladder cancer?
-
8:08
gene mutations as predictive biomarkers for cisplatin-based chemotherapy response in bladder cancer
-
19:21
immunotherapy for muscle invasive bladder cancer
-
0:21
there are multiple dynamic biomarkers for bladder cancer
-
2:43
genomic insights and biomarkers for treatment selection in bladder cancer